首页> 外国专利> A PROCESS FOR THE CHARACTERIZATION OF THE BIOACTIVE COMPONENT PRESENT IN BARK AND ROOT OF AZADIRACHTA INDICA (NEEM) USED IN HERBAL REMEDIES FOR THE TREATMENT OF DIABETIC

A PROCESS FOR THE CHARACTERIZATION OF THE BIOACTIVE COMPONENT PRESENT IN BARK AND ROOT OF AZADIRACHTA INDICA (NEEM) USED IN HERBAL REMEDIES FOR THE TREATMENT OF DIABETIC

机译:一种用于治疗糖尿病的草药中印度金刚鹦鹉树皮和根中生物活性成分的表征方法

摘要

Hypoglycemic activity of Azadirachta indica(Neem ) which is used in the treatment of diabetics is known. But bioactive component responsible for hypoglycemic activity remained unknown. The invention characterizes the bioactivity, present in alcoholic extract or in low molecular weight fraction (5000 dalton ) of aqueous extract of bark and root of the plant , reversibly inhibiting maltase and sucrase enzyme activities. In the digestion of starch, pancreatic amylase produces maltose from starch . Maltose as well as any sucrose if taken, are hydrolysed at the epithelium of the small intestine by membrane-bound maltase and sucrase into glucose or glucose and fructose.. Many low molecular weight maltase and sucrase inhibitors (acarbose, miglitol, valiolamine derivative) are clinically used for the treatment of type-II or insulin-independent diabetes Therapy is achieved by delaying glucose absorption into the blood stream due to inhibition of epithelial sucrase and maltase activities. The present invention characterized similar activity present in Azadirachta indica(Neem which could control inflow of glucose into blood after starch digestion. The active inhibitors molecule (s) may be a potential ant-diabetic drug or a lead molecule for future drug development. The present invention provides a process for the characterization of inhibitory activities of aqueous or alcoholic extract of Azadirachta indica root or bark on maltase and sucrase activities, which comprise collection of fresh or dried uninfected bark or roots of Azadirachta indica, washing them with water, blending in blender to paste, separating the aqueous solution by pressure filtration, further filtering the solution by ultrafiltration membrane of 5,000 dalton cut, collecting the filtrate and drying the solution in a lyophilizer, and characterizing the inhibitory activities of the fraction on activities of maltase and sucrase or extracting hand milled powder of root and bark each separately with ethyl alcohol for 24 hours, collecting the filtrates, removing alcohol by evaporation of the solvent 50°C and characterizing the inhibitory activities of dried powder on maltase and sucrase. In typical experiments, aqueous extraction gave 2.2 and 2 grams of solid from 100gm of dry bark and root respectively and ethanol extraction gave 2 and 1.4 grams of solid from 100 grams of dry bark and root respectively. Ki and IC50 values of the solids on maltase and sucrase of both mammalian and microbial origins were determined.
机译:已知用于治疗糖尿病的印A(Azadirachta indica(Neem))的降血糖活性。但是负责降血糖活性的生物活性成分仍然未知。本发明表征了存在于酒精提取物中或存在于植物的树皮和根部的水提取物中的低分子量级分(5000道尔顿)中的生物活性,可逆地抑制了麦芽糖酶和蔗糖酶的活性。在淀粉的消化中,胰淀粉酶从淀粉中产生麦芽糖。麦芽糖和任何蔗糖(如果服用的话)在小肠的上皮被膜结合的麦芽糖酶水解,并蔗糖酶转化为葡萄糖或葡萄糖和果糖。临床上用于治疗II型或非胰岛素依赖型糖尿病的疗法是通过抑制葡萄糖对上皮蔗糖酶和麦芽糖酶活性的吸收而延迟进入血流中来实现的。本发明的特征在于印A中的印similar具有类似的活性,它可以控制淀粉消化后葡萄糖向血液中的流入。该活性抑制剂分子可以是潜在的抗糖尿病药物或用于未来药物开发的先导分子。本发明提供了表征印za(Azadirachta indica)根或树皮的水或醇提取物对麦芽糖酶和蔗糖酶活性的抑制活性的方法,该方法包括收集新鲜或干燥的未感染印za(Azadirachta)的树皮或根,用水洗涤,在搅拌机中混合。糊状,通过压力过滤分离水溶液,进一步用5,000道尔顿切口的超滤膜过滤溶液,收集滤液并在冻干机中干燥溶液,并表征级分对麦芽糖酶和蔗糖酶或提取的抑制活性根和树皮分别与乙基铝分别手工研磨的粉末乙醇发酵24小时,收集滤液,在50°C蒸发溶剂除去乙醇,并表征干燥粉末对麦芽糖酶和蔗糖酶的抑制活性。在典型的实验中,水提取分别从100克干树皮和根中得到2.2克和2克固体,乙醇提取分别从100克干树皮和根中得到2克和1.4克固体。测定了哺乳动物和微生物来源的麦芽糖酶和蔗糖酶上的固体的Ki和IC50值。

著录项

  • 公开/公告号IN2007KO00617A

    专利类型

  • 公开/公告日2008-11-07

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN617/KOL/2007

  • 发明设计人 SENGUPTA SHUBABRATA;MUKHERJEE ABHISHEK;

    申请日2007-04-20

  • 分类号A61K36/27;

  • 国家 IN

  • 入库时间 2022-08-21 20:07:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号